Primary Device ID | 05060604130034 |
NIH Device Record Key | 68b6820a-cd06-407a-8d55-c9dcf6f7f686 |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | Synvisc One |
Version Model Number | NA |
Company DUNS | 218668297 |
Company Name | ACRE PHARMA LIMITED |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | true |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Storage Environment Temperature | Between 2 Degrees Celsius and 30 Degrees Celsius |
Device Issuing Agency | Device ID |
---|---|
GS1 | 05060604130034 [Primary] |
MOZ | Acid, Hyaluronic, Intraarticular |
Steralize Prior To Use | false |
Device Is Sterile | true |
Public Version Status | Update |
Device Record Status | Published |
Public Version Number | 2 |
Public Version Date | 2018-07-27 |
Device Publish Date | 2018-04-27 |
05060604130065 - Monovisc | 2019-02-14 |
05060604130041 - Synvisc | 2018-08-27 |
05060604130034 - Synvisc One | 2018-07-27Inject into the knee to relieve the pain from osteoarthritis. |
05060604130034 - Synvisc One | 2018-07-27 Inject into the knee to relieve the pain from osteoarthritis. |
05060604130003 - Euflexxa | 2018-05-28 Injected into the knee to relieve the pain from osteoarthritis. |
05060604130010 - Orthovisc | 2018-05-28 Inject into the knee to relieve the pain caused by osteoarthritis. |
05060604130027 - Supartz | 2018-05-28 Injected into the knee to relieve the pain from osteoarthritis. |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SYNVISC ONE 77228235 3521857 Live/Registered |
Genzyme Corporation 2007-07-12 |
SYNVISC ONE 77171821 not registered Dead/Abandoned |
Genzyme Corporation 2007-05-03 |